1. Home
  2. EVO vs AWF Comparison

EVO vs AWF Comparison

Compare EVO & AWF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • AWF
  • Stock Information
  • Founded
  • EVO 1993
  • AWF 1993
  • Country
  • EVO Germany
  • AWF United States
  • Employees
  • EVO N/A
  • AWF N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • AWF Trusts Except Educational Religious and Charitable
  • Sector
  • EVO Health Care
  • AWF Finance
  • Exchange
  • EVO Nasdaq
  • AWF Nasdaq
  • Market Cap
  • EVO 1.2B
  • AWF 973.5M
  • IPO Year
  • EVO 2021
  • AWF N/A
  • Fundamental
  • Price
  • EVO $3.73
  • AWF $11.38
  • Analyst Decision
  • EVO Buy
  • AWF
  • Analyst Count
  • EVO 2
  • AWF 0
  • Target Price
  • EVO $5.40
  • AWF N/A
  • AVG Volume (30 Days)
  • EVO 41.5K
  • AWF 190.0K
  • Earning Date
  • EVO 11-05-2025
  • AWF 01-01-0001
  • Dividend Yield
  • EVO N/A
  • AWF 7.57%
  • EPS Growth
  • EVO N/A
  • AWF N/A
  • EPS
  • EVO N/A
  • AWF N/A
  • Revenue
  • EVO $912,894,891.00
  • AWF N/A
  • Revenue This Year
  • EVO $0.39
  • AWF N/A
  • Revenue Next Year
  • EVO $9.53
  • AWF N/A
  • P/E Ratio
  • EVO N/A
  • AWF N/A
  • Revenue Growth
  • EVO N/A
  • AWF N/A
  • 52 Week Low
  • EVO $2.84
  • AWF $9.20
  • 52 Week High
  • EVO $5.64
  • AWF $10.67
  • Technical
  • Relative Strength Index (RSI)
  • EVO 57.04
  • AWF 64.54
  • Support Level
  • EVO $3.43
  • AWF $11.20
  • Resistance Level
  • EVO $3.55
  • AWF $11.34
  • Average True Range (ATR)
  • EVO 0.08
  • AWF 0.06
  • MACD
  • EVO 0.05
  • AWF 0.00
  • Stochastic Oscillator
  • EVO 90.27
  • AWF 97.22

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About AWF Alliancebernstein Global High Income Fund

Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.

Share on Social Networks: